Alembic Pharma reports stellar Q4 numbers

02 May 2013 Evaluate

Alembic Pharmaceuticals has reported results for the fourth quarter & year ended March 31, 2013.

The company has reported a surge of 114.92% in its net profit at Rs 43.65 crore in Q4FY13 as compared to net profit of Rs 20.31 crore in the same quarter previous year. Total income from operation of the company rose by 10.44% to Rs 378.08 crore as compared to Rs 342.34 crore in corresponding quarter last year.

For the full year, the company has reported a net profit of Rs 165.25 crore for the year ended March 31, 2013, a surge of 26.98% as compared to Rs 130.14 crore for the year ended March 31, 2012. Total income has increased to Rs 1520.34 crore in FY13 from Rs 1465.41 crore in FY12, up by 3.75%.

Alembic Pharma Share Price

899.90 -2.30 (-0.25%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×